NovaSeq 6000 Sequencing System is by far our most powerful instrument, designed to adapt to your needs.
Kits & Reagents
P1 reagents are now available for NextSeq 1000/NextSeq 2000 Systems, offering added flexibility to meet your project's needs
Selection & Planning Tools
A high-performing, fast, and integrated workflow for sensitive applications such as human whole-genome sequencing
Software & Informatics Products
DRAGEN v3.9 release now available with multi-cloud support, accuracy improvements and more
Fast, high-quality, sample-to-data services such as RNA and whole-genome sequencing
Improved Q30 score, support for UMIs, extended shelf life, and support for Illumina DNA PCR-Free Library Prep
See what is possible through the latest advances in high-throughput sequencing technology
Illumina and the San Diego Zoo Wildlife Alliance try to preserve the species with the help of genomic data
All Investor Information
All Legal Information
Upgrade your MiSeqDx instrument from Windows 7 to Windows 10
All Support Tools
Product Support Services
Multiomics methods can better connect genotype to phenotype
Cancer Research Products
Microbial Genomics Research
Learn about methods for SARS-CoV-2 surveillance, including requirements, workflow, and analysis
Microbial Genomics Products
Array-based SNP genotyping platforms have low genotype error rates compared to genotyping-by-sequencing
Explore the advantages of NGS for analysis of gene expression, gene regulation, and methylation
Complex Disease Research Products
Prof. Dr. Bernd Eiben discusses his experience with VeriSeq NIPT Solution v2
Reproductive Health Products
Illumina supports the release of a landmark consensus on whole-genome sequencing in the diagnosis of genetic diseases in newborns
Genetic Health Products
Illumina researchers developed a robust workflow for sequencing RNA in the blood, obtaining a noninvasive snapshot of whole-body health with the potential of transforming the future of diagnostics.
The Infinity technology platform will help researchers address the edges of the genome that are the most challenging to map.
Learn how the Illumina DRAGEN platform with its advancements in machine learning and graph genome provides the most accurate view of the human genome in PrecisionFDA Truth Challenge V2.
Learn how your choice of human reference genome can affect mapping and variant calling ability.
Learn how to save compute time and storage costs for genomic data by using DRAGEN ORA, a totally lossless compression technology for FASTQ files.
We can use aggregated alignment metrics from populations to predict how well we can call variants in any sample. This empirical approach finds very high quality regions and outperforms reference-based methods.
The Illumina Connected Analytics (ICA) platform is the foundation on which a customized genomics analysis environment is built, managing and processing large amounts of heterogenous data sets.
The DRAGEN platform calls both small and large variants from population genetics studies with high precision and speed.
DRAGEN recently won the PrecisionFDA Truth Challenge V2 contest for Illumina reads in the Difficult-to-Map and All-Benchmark Regions categories.
SMNCopyNumberCaller enables accurate copy number calling of the highly similar SMN1 and SMN2 for spinal muscular atrophy diagnosis/carrier screening.
SpliceAI, a 32-layer deep neural network, predicts splicing from pre-mRNA sequences and identifies cryptic splice variants in rare disease patients.
REViewer is a computational method for visualization of sequencing data in genomic regions containing long repeat expansions.
CYP2D6 metabolizes 21% of clinically used drugs. Cyrius resolves common SVs and sequence homology to paralog and genotypes CYP2D6 with 99.3% accuracy.
Paragraph is a graph aligner and variant caller that can accurately genotype known structural variants using the aligned sequence reads.
The Illumina team developed deep neural network algorithm, PrimateAI, to predict the clinical impact of human missense mutations.